The global geothermal heat pumps market players are struggling to achieve a steady and noticeable position in the market through product improvement while the level of rivalry amongst them is extreme. The global geothermal heat pumps mar…
BMI View: Ghana remains an attractive investment prospect for foreign drugmakers operating in Sub-
Saharan Africa, and stabilising the national health insurance scheme provides an upside risk to our outlook
for the pharmaceutical sector. The Ghanaian government is actively making progress towards fulfilling its
ambition of being the Economic Communities of West African States (ECOWAS) hub for pharmaceutical
and healthcare investment.
Headline Expenditure Projections
Pharmaceuticals: GHS1.18bn (USD310mn) in 2015 to GHS1.30bn (USD320mn) in 2016; +10.9% in local
currency terms and +4.3% in US dollar terms. Forecast in line with Q316.
Healthcare: GHS4.39bn (USD1.16bn) in 2015 to GHS4.78bn (USD1.19bn) in 2016; +8.9% in local
currency terms and +2.4% in US dollar terms. Forecast in line with Q316.